We are live on ! Find out more
PVMCI

Polaris Venture Management Co IV Portfolio holdings

AUM $62.4M
1-Year Est. Return 33.04%
This Fund
S&P 500
This Quarter Est. Return
-28.77%
1 Year Est. Return
+33.04%
3 Year Est. Return
+52.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$56.9M
AUM Growth
-$39.2M
Cap. Flow
-$12.2M
Cap. Flow %
-21.52%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
1
DELISTED
Acceleron Pharma
XLRN
$36.9M 64.78%
1,480,060
-407,259
-22% -$12.2M
PULM icon
2
Pulmatrix
PULM
$6.35M
$7.82M 13.74%
7,959
– –
ALIM
3
DELISTED
Alimera Sciences
ALIM
$6.96M 12.23%
209,890
– –
DARE icon
4
Dare Bioscience
DARE
$18.3M
$5.26M 9.25%
11,979
– –

Similar funds

HCM
Hayman Capital Management Dallas, Texas $63.3M AUM 3.78% 1-Year Est. Return
LVP
Limestone Value Partners Houston, Texas $64M AUM 4.56% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
HWM
Heartwood Wealth Management London, United Kingdom $58.9M AUM 14.96% 1-Year Est. Return
CCG
Crescent Capital Group Los Angeles, California $56.8M AUM 11.67% 1-Year Est. Return
CSM
Central Square Management Naperville, Illinois $56.6M AUM 27.75% 1-Year Est. Return
KCP
Keane Capital Partners Charlotte, North Carolina $56M AUM
EL
Elberon LLC Austin, Texas $56M AUM 14.07% 1-Year Est. Return

Polaris Venture Management Co IV's Q3 2015 Portfolio in Review

As of Q3 2015, Polaris Venture Management Co IV held 4 positions worth $56.9M, down 41% from $96.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co IV withdrew a net $12.2M in Q3 2015, reducing 1 holding. Its largest reduction was Acceleron Pharma, cutting an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co IV's biggest Q3 2015 reduction was Acceleron Pharma, cutting an estimated $12.2M.
  • Polaris Venture Management Co IV's ten largest holdings make up 100% of its $56.9M portfolio in Q3 2015.
  • Polaris Venture Management Co IV opened 0 new positions and closed 0 in Q3 2015.
  • Polaris Venture Management Co IV's portfolio value fell 41% quarter-over-quarter to $56.9M.

Based on Polaris Venture Management Co IV's 13F filing for Q3 2015, filed 10 Nov 2015.